BEIT is a company headquartered in the United States.
BEIT provides an integrated computational pipeline using physics-based modeling to support small-molecule drug discovery, including target preparation, virtual screening, and free-energy perturbation calculations.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.